Barclays PLC purchased a new position in Innovator U.S. Equity Accelerated Plus ETF – April (BATS:XTAP – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 5,563 shares of the company’s stock, valued at approximately $187,000. Barclays PLC owned approximately 2.47% of Innovator U.S. Equity Accelerated Plus ETF – April as of its most recent filing with the Securities and Exchange Commission.
Innovator U.S. Equity Accelerated Plus ETF – April Stock Performance
Shares of XTAP opened at $34.83 on Tuesday. The stock has a market cap of $7.84 million, a price-to-earnings ratio of 23.84 and a beta of 0.56. The firm’s 50-day moving average is $34.49 and its 200 day moving average is $33.48.
About Innovator U.S. Equity Accelerated Plus ETF – April
Further Reading
- Five stocks we like better than Innovator U.S. Equity Accelerated Plus ETF – April
- Why Invest in High-Yield Dividend Stocks?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Compound Interest and Why It Matters When Investing
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding XTAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innovator U.S. Equity Accelerated Plus ETF – April (BATS:XTAP – Free Report).
Receive News & Ratings for Innovator U.S. Equity Accelerated Plus ETF - April Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator U.S. Equity Accelerated Plus ETF - April and related companies with MarketBeat.com's FREE daily email newsletter.